skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

297 Total results for product and free and sample content found


Podcast: Scaling Up Your Business

27 Jun 2017

BIO International 2017 discussion: growing a biotech business.

Topic Business strategies

Medtech Insight

Virtual Reality: The New Game In Mental Health Care To Improve Outcomes

26 Jun 2017

Virtual reality is seeing an upsurge in use by mental health practitioners for treating conditions such as post-traumatic stress disorder.

Medtech Insight

Discover the top medtech stories from the last week below

By Frank Montana 26 Jun 2017

Meddevicetracker weekly round up

Topic Medtech Medtech weekly roundup

Pink Sheet

Pfizer’s EPO Biosimilar Stalls In US On Hospira Compliance Woes

By Sue Sutter 26 Jun 2017

US FDA hands Pfizer its second complete response letter for its proposed biosimilar to Epogen/Procrit.

Topic Biosimilars

Medtech Insight

Q&A: FDA Dx Reviewer's Tips For Next-Gen Sequencing Sponsors

26 Jun 2017

A top reviewer in US FDA's in vitro diagnostics office offers tips to next-generation sequencing test sponsors to avoid common submission shortcomings.

Topic Personalized Medicine


Shire CEO: Mydayis To Be Big ADHD Drug, But No Ex-US Launch Planned (Yet)

By Sten Stovall 26 Jun 2017

Flemming Ornskov says FDA approval of long-lasting ADHD therapy Mydayis.

Pink Sheet

Key Indian Panel Go-Ahead For Novartis’ Kisqali

By Anju Ghangurde 26 Jun 2017

Just months after the US FDA cleared Kisqali, Novartis appears on course to bring the breast cancer therapy to India after a key local expert panel.

Topic Cancer


AbbVie's New Hep C Drug Will Break Gilead's Dominance If Approved In EU

By Lucie Ellis 26 Jun 2017

AbbVie and Gilead's latest hepatitis C therapies are anticipated to win positive recommendations for approval in Europe.

Pharma Consulting

Informa Pharma Consulting appoints healthcare communications leader as Global Director

26 Jun 2017

Leading provider of strategic solutions for pharmaceutical industry professionals, Informa Pharma Consulting, has appointed Richard Veal as Global Director.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: